D2 procedure has been accepted in Far East as the standard treatment for both early (EGC)
and advanced gastric cancer (AGC) for many decades. Recently EGC has been successfully …

Significant variability exists throughout the world in the extent of lymphadenectomy that is
performed for gastric adenocarcinoma. D2 lymphadenectomy is the standard …

Background The aim of this multicenter retrospective study was to establish background
data for future randomized clinical trial comparing open and laparoscopy-assisted …

AIM: To investigate feasibility, morbidity and surgical mortality of a docetaxel-based
chemotherapy regimen randomly administered before or after gastrectomy in patients …

BACKGROUND: Controversies exist about feasibility and oncologic effectiveness of
laparoscopic gastrectomies with extended lymphadenectomy for advanced gastric cancer …

Gastric cancer is a unique malignancy, with definite geographic differences in incidence,
pathology, treatment and outcome. While the incidence has been declining in the Western …

Background The objective of the present meta‐analysis was to estimate the magnitude of
survival and recurrence free benefits from different lymphadenectomy in patients with …

PURPOSE: This study was designed to establish whether the number of lymph nodes
removed has an effect on prognosis in patients with node-negative gastric cancer …

In a non-specialized setting, laparoscopic distal gastrectomy (LDG) for locally advanced
diseases remains controversial, particularly given to the technical demands of the learning …

AIM: To evaluate the impact of splenectomy on long-term survival, postoperative morbidity
and mortality of patients with gastric cancer by performing a meta-analysis. METHODS: A …